Literature DB >> 7788136

Economics of treatment of depression.

N Freemantle, A House, J Mason, F Song, T Sheldon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7788136     DOI： 10.1192/bjp.166.3.397

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN： 0007-1250            Impact factor:   9.319


× No keyword cloud information.
  5 in total

Review 1.  The generalisability of pharmacoeconomic studies.

Authors:  J Mason
Journal:  Pharmacoeconomics       Date:  1997-06       Impact factor: 4.981

2.  Meta-analysis of antidepressant prescribing. Drop out rates presented in a misleading manner.

Authors:  N Freemantle; J Mason
Journal:  BMJ       Date:  1995-09-16

Review 3.  Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders.

Authors:  N S Gunasekara; S Noble; P Benfield
Journal:  Drugs       Date:  1998-01       Impact factor: 9.546

Review 4.  Paroxetine. A pharmacoeconomic evaluation of its use in depression.

Authors:  M I Wilde; R Whittington
Journal:  Pharmacoeconomics       Date:  1995-07       Impact factor: 4.981

Review 5.  Fluoxetine. A pharmacoeconomic review of its use in depression.

Authors:  M I Wilde; P Benfield
Journal:  Pharmacoeconomics       Date:  1998-05       Impact factor: 4.981
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.